| Code | 2866A | ||||||||||
| MA number | 44/0436/12-S | ||||||||||
| Product Form: | sol ijf 1x20 ml/2000 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 18 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Subcutaneous and intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 28.09.2012 |
| Pediatric indication: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Cytarabin Kabi 100 mg/ml_01/2021.doc
|
| SPC: |
SPC_Cytarabin Kabi 100 mg/ml_01/2021.doc
|
| Safety feature | Yes |
| Data update: | 29.05.2018 |
